Article: P3.17 Azacytidine prevents experimental sclerodermic chronic graft-versus-host disease

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer